Javascript must be enabled to continue!
Formulation optimization of mouth dissolving tablets of Meloxicam using mixed hydrotropic solublization technique
View through CrossRef
The objective of the present study was to develop mouth dissolving tablets of meloxicam in order to achieve rapid release in saliva which may result in enhanced absorption and thereby improved bioavailability. Six batches of mixed hydrotropic solid dispersions and physical mixtures were prepared using different ratios (1:2, 1:4 and 1:6) of hydrotropic blends (urea, Nicotinamide & sodium citrate). The best batch was selected to prepare mouth dissolving tablets comprising solid dispersion of Meloxicam in six preliminary batches using croscarmellose sodium & crospovidone as superdisintegrants and camphor as subliming agent in different ratios along with other excipients. Secondary batches were prepared based on 32 factorial design with amount of superdisintegrant (crospovidone) and camphor (subliming agent) as two independent formulation variables. Two dependent response variables considered were disintegration time and percentage friability. All the batches of mouth dissolving tablets were evaluated for pre-compre sion parameters and post-compression parametes. The results of accelerated stability studies revealed no physical and chemical changes in the tablets during three months.
BioMed Research Publishers
Title: Formulation optimization of mouth dissolving tablets of Meloxicam using mixed hydrotropic solublization technique
Description:
The objective of the present study was to develop mouth dissolving tablets of meloxicam in order to achieve rapid release in saliva which may result in enhanced absorption and thereby improved bioavailability.
Six batches of mixed hydrotropic solid dispersions and physical mixtures were prepared using different ratios (1:2, 1:4 and 1:6) of hydrotropic blends (urea, Nicotinamide & sodium citrate).
The best batch was selected to prepare mouth dissolving tablets comprising solid dispersion of Meloxicam in six preliminary batches using croscarmellose sodium & crospovidone as superdisintegrants and camphor as subliming agent in different ratios along with other excipients.
Secondary batches were prepared based on 32 factorial design with amount of superdisintegrant (crospovidone) and camphor (subliming agent) as two independent formulation variables.
Two dependent response variables considered were disintegration time and percentage friability.
All the batches of mouth dissolving tablets were evaluated for pre-compre sion parameters and post-compression parametes.
The results of accelerated stability studies revealed no physical and chemical changes in the tablets during three months.
Related Results
Meloxicam Inhibits Hepatocellular Carcinoma Progression and Enhances the Sensitivity of Immunotherapy via the MicroRNA-200/PD-L1 Pathway
Meloxicam Inhibits Hepatocellular Carcinoma Progression and Enhances the Sensitivity of Immunotherapy via the MicroRNA-200/PD-L1 Pathway
Background. Hepatocellular carcinoma (HCC) has become the sixth most common cancer and the third leading cause of cancer death in the world. Although the research achievements of t...
Mouth Dissolving Tablets – A Review
Mouth Dissolving Tablets – A Review
Conventional dosage form such as tablets and capsules are the most popular among all dosage forms existing today because of its convenience of self administration, compactness and ...
Effect of administration of ajwa date extract on renal histopathological changes in meloxicam induced in rats
Effect of administration of ajwa date extract on renal histopathological changes in meloxicam induced in rats
Objective: This study aimed to examine the nephroprotector effect of ajwa date extract on the kidneys of white rats induced by meloxicam. Methods: 25 male (Rattus norvegicus) rats ...
A Review on Mouth Dissolving Tablets and Meloxicam
A Review on Mouth Dissolving Tablets and Meloxicam
Mouth dissolving tablets (MDTs) have emerged as a novel dosage form designed to enhance patient compliance and therapeutic efficacy, particularly for pediatric, geriatric, and dysp...
Penentuan Kadar Meloksikam Sediaan Tablet Dari Berbagai Apotek Yang Terdapat Di Rantau Prapat Secara Spektrofotometri – UV
Penentuan Kadar Meloksikam Sediaan Tablet Dari Berbagai Apotek Yang Terdapat Di Rantau Prapat Secara Spektrofotometri – UV
Meloxicam is a non-steroidal anti-inflammatory drug that can relieve arthritis symptoms, such as inflammation, swelling, and muscle stiffness and pain, by acting as an inhibitor of...
Formulation and Evaluation of Fast Disintigrating Meloxicam Tablets and Its Comparison with Marketed Product
Formulation and Evaluation of Fast Disintigrating Meloxicam Tablets and Its Comparison with Marketed Product
The present investigation deals with the formulation of fast disintegrating tablets of Meloxicam that disintegrate in the oral cavity upon contact with saliva and there by improve ...
Real-world data on the effectiveness of the meloxicam and pridinol combination for musculoskeletal pain
Real-world data on the effectiveness of the meloxicam and pridinol combination for musculoskeletal pain
Musculoskeletal pain includes several types of discomfort associated with the skeletal system. Pharmaceutically, pridinol was developed in order to relax muscles. No empirical data...
Meloxicam‐Induced Thrombocytopenia
Meloxicam‐Induced Thrombocytopenia
Immune thrombocytopenia can have several causes including the use of certain drugs. Thrombocytopenia has been documented as a rare adverse effect of some nonsteroidal antiinflammat...

